The global minimally invasive surgical instruments market size is expected to reach USD 38.3 billion by 2025 according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 9.7% over the forecast period. The preference for Minimally Invasive Surgical (MIS) procedures is rising as they are less traumatic and they facilitate faster recover process than traditional open surgeries.
Minimal invasive technologies are designed to reduce trauma, blood loss, scarring, and chances of infection than traditional open surgeries. Patients can resume their daily activities in shorter time after these surgical procedures. In addition, the costs involved in minimally invasive surgeries are significantly less than in-patient and conventional open surgeries. Therefore, MIS procedures prove to be beneficial for patients as well as payers. The benefits of MIS in various areas of orthopedics have contributed to the growing demand for less traumatic alternatives with minimum tissue disruption of bones.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
- Handheld instruments led the device segment in terms of revenue share in 2017. On the other hand, electrosurgical devices are expected to witness the fastest CAGR during the forecast period
- Orthopedic led the application segment in terms of revenue share in 2017 owing to easy surgical alternatives with minimum tissue disruption in the form of MIS procedures
- Continuous adoption of MIS techniques for spine related procedures has led to the expansion of procedural volumes for orthopedic MIS
- Hospital segment held a majority of the market share in 2017. On the other hand, the Ambulatory Surgical Centers segment is likely to experience the fastest growth in the forthcoming years
- Ambulatory surgical centers offer same day surgery and discharge at lower costs. At present, over 5,500 Medicare certified ambulatory care centers are present in U.S.
- North America held majority of the market share in 2017 due to the presence of supportive reimbursement framework for innovative MIS devices and procedures
- Medtronic; Abbott; NuVasive, Inc.; CONMED; Stryker; Smith & Nephew; Zimmer Biomet; and Intuitive Surgical, Inc. are some of the key players operating in the minimally invasive surgical instruments market.
No comments:
Post a Comment